← American Pharmacists Association (APhA)
HHSNonrulemakingHHS-ONC-2026-0001

Request for Information: Accelerating the Adoption and Use of Artificial Intelligence as Part of Clinical Care

RIN
—
Last modified
Jan 27, 2026
Comment window
closed 155d ago
American Pharmacists Association (APhA) filings
1

Activity

American Pharmacists Association (APhA) filed 1 comment on this docket between Feb 24, 2026 and Feb 24, 2026. 136 other organizations filed here. The comment window closed 155d ago.

What American Pharmacists Association (APhA) filed (1)

Feb 24, 2026· Comment from American Pharmacists Association, HHS-ONC-2026-0001, HHS-ONC-2026-0001-0001, 2025-23641· HHS-ONC-2026-0001-0287

Dear Secretary Kennedy, The American Pharmacists Association (APhA) appreciates the opportunity to provide comments on CMS's "Accelerating the Adoption and Use of Artificial Intelligence as Part of Clinical Care," request for information. APhA writes to CMS to offer comments on behalf of our pharmacist members on artificial intelligence (AI). In 2024, APhA's House of Delegates (HOD) adopted the following resolution: Artificial Intelligence Use in Pharmacy Practice 1. APhA opposes the replacement of a pharmacist's professional judgment or patient's access to their pharmacist with artificial intelligence. 2. APhA calls on the profession of pharmacy and all related organizations to proactively assess and respond to the evolving role of artificial intelligence in pharmacy practice and workforce dynamics. 3. APhA encourages judicious use of artificial intelligence by pharmacists and pharmacy personnel as a tool to elevate pharmacy practice and enhance patient care. 4. APhA advocates for the integration of pharmacists into the development, design, validation, implementation, and maintenance of artificial intelligence solutions. 5. APhA calls on regulatory bodies, employers, and other relevant parties to develop laws, regulations, and policies as applicable for artificial intelligence to ensure patient safety, privacy, public awareness, and public protection. 6. APhA calls on those providing artificial intelligence solutions to implement processes that identify and mitigate bias and misinformation in artificial intelligence. 7. APhA advocates for education providers to facilitate, and pharmacy personnel to seek out, education and training on the lawful, ethical, and clinical use of artificial intelligence. APhA represents pharmacists, student pharmacists, and pharmacy technicians in all practice settings, including but not limited to community pharmacies, hospitals, long-term care facilities, specialty pharmacies, community health centers, physician offices, ambulatory clinics, managed care organizations, hospice settings, and government facilities. Our members strive to improve medication use, advance patient care, and enhance public health. Full comments are attached.

View on regulations.gov →

Abstract

HHS Health Sector AI RFI The HHS Office of the Deputy Secretary in collaboration with ASTP/ONC has published this Request for Information (RFI) to seek broad public comment on what HHS can do to accelerate the adoption and use of AI as part of clinical care.

View on regulations.gov →

Co-filers (136)

See everyone who commented →